SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-027952
Filing Date
2017-04-28
Accepted
2017-04-28 16:47:50
Documents
6
Period of Report
2017-04-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-11998_48k.htm 8-K 24320
2 EX-99.1 a17-11998_4ex99d1.htm EX-99.1 33195
3 GRAPHIC g119984mm01i001.jpg GRAPHIC 47506
4 GRAPHIC g119984mm03i001.jpg GRAPHIC 121720
5 GRAPHIC g119984mm05i001.jpg GRAPHIC 3091
6 GRAPHIC g119984mm09i001.jpg GRAPHIC 26063
  Complete submission text file 0001104659-17-027952.txt   332521
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 17796457
SIC: 2834 Pharmaceutical Preparations